ARTICLE | Company News
Evotec, C4X Discovery deal
October 3, 2016 7:00 AM UTC
The companies partnered to develop small molecule candidates against undisclosed targets, with initial programs aimed at cancer and autoimmune diseases. C4X will retain all IP and licensing rights for...